therapeutics News and Research

RSS

New gel enhances immunotherapy's effectiveness in glioblastoma

Pairing a newly developed gel with immunotherapy that was delivered to post-surgical mouse brains with glioblastoma, a highly malignant and deadly cancer, improved the immunotherapy's effectiveness, report researchers from the University of North Carolina Lineberger Comprehensive Cancer Center and colleagues.

7 Oct 2021

Common drug to treat cancer reverses Alzheimer’s symptoms in mice

A drug commonly used to treat cancer can restore memory and cognitive function in mice that display symptoms of Alzheimer's disease, new UBC research has found.

6 Oct 2021

Researchers identify 14 genes responsible for obesity

Promising news in the effort to develop drugs to treat obesity: University of Virginia scientists have identified 14 genes that can cause and three that can prevent weight gain. The findings pave the way for treatments to combat a health problem that affects more than 40% of American adults.

4 Oct 2021

Powerful method offers new insights about the dynamics of gliomas

A team led by researchers at Weill Cornell Medicine, the New York Genome Center, Harvard Medical School, Massachusetts General Hospital and the Broad Institute of MIT and Harvard has profiled in unprecedented detail thousands of individual cells sampled from patients' brain tumors.

4 Oct 2021

Researchers develop key components of an expanded genetic code system

Modern biologists nurture more ambitious goals and one among them is to know how to broaden or alternatively modify the genetic code of life on Earth.

1 Oct 2021

Gene expression changes help understand the mechanism behind noise-induced hearing loss

A growing number of people are suffering from hearing loss due to exposure to loud noises from heavy machinery, concerts, or explosions. As a result, scientists have been working to understand the mechanism behind how the damage to hearing actually occurs.

30 Sep 2021

Researchers identify new protein that may critically contribute to severe COVID-19

The University of Kent's School of Biosciences and the Institute of Medical Virology at Goethe-University, Frankfurt am Main, have identified a protein that may critically contribute to severe forms of COVID-19.

27 Sep 2021

Exploring cell and gene based therapies for Parkinson’s disease

After several decades of pre-clinical development, cell- and gene-based therapies for Parkinson's disease (PD) are now actively being explored. In this special supplement to the Journal of Parkinson's Disease on "Repairing the Parkinsonian Brain," experts highlight some of the current strategies being pursued to restore lost function and replace what is lost in the PD brain, with special emphasis on the challenges associated with translating advanced therapeutic approaches into pioneering clinical trials.

24 Sep 2021

Researchers identify host entry factor for Rift Valley fever virus

Rift Valley fever virus causes economically devastating outbreaks of hemorrhagic fever in livestock such as sheep, goats and cattle. These mosquito-borne outbreaks lead to infection in people working with dead or dying animals, sometimes causing hundreds of human cases and dozens of deaths.

24 Sep 2021

New map provides a reference to predict which antibodies are effective against SARS-CoV-2

Scientists at La Jolla Institute for Immunology have published a detailed map of where human antibodies bind to SARS-CoV-2, a map that was generated by a global collaboration comparing nearly all leading clinical candidates.

24 Sep 2021

Researchers show how 'bad mucin' contributes to worsening pulmonary conditions

Mucus is an essential protective layer of gel-like liquid composed largely of proteins called mucins throughout our airways.

23 Sep 2021

Researchers find a new way to counter immunosuppressive effect in tumors

Malignant tumors can enhance their ability to survive and spread by suppressing antitumor immune cells in their vicinity, but a study led by researchers at Weill Cornell Medicine and NewYork-Presbyterian has uncovered a new way to counter this immunosuppressive effect.

21 Sep 2021

Study outlines the advantages of organoids for basic research into coronaviruses

Scientists created an organoid biobank to investigate the genes that are vital for the spreading of a SARS-CoV-2 infection.

21 Sep 2021

Study reveals how the tumor suppressor gene plays a vital role in pediatric rhabdomyosarcoma

Scientists at St. Jude Children's Research Hospital have revealed how the tumor suppressor gene PTEN plays a more important role in pediatric rhabdomyosarcoma than was previously appreciated.

20 Sep 2021

Scientists discover a new enzymatic complex that can halt cells from aging

Researchers at Université de Montréal and McGill University have discovered a new multi-enzyme complex that reprograms metabolism and overcomes “cellular senescence,” when aging cells stop dividing.

17 Sep 2021

UTHSC researcher receives grant to extend work on The Cancer Genome Atlas project

Neil Hayes, MD, MPH, director of the Center for Cancer Research at the University of Tennessee Health Science Center, is one of two principal investigators for a $1.8 million grant that extends the work of The Cancer Genome Atlas (TCGA), a groundbreaking multisite project to understand cancer at its molecular level through genome sequencing and extensive data analysis.

16 Sep 2021

New drug-based genetic platform offers a simpler, more efficient way to study gene function

Studying the role genes play on basic biology and disease is now easier, faster and more efficient, say researchers at Baylor College of Medicine.

15 Sep 2021

Scientists devise a strategy to enhance anti-tumor immunity

A synthetic molecular code exhibits the potential of enhancing the response of certain cancer patients to immunotherapy treatments.

15 Sep 2021

New technology harnesses a natural feature of therapeutic antibodies to attack blood cancer cells

Researchers at the University of Southampton and biopharma company UCB have found a way to enhance the natural ability of therapeutic antibodies to attack blood cancer cells using part of the human immune system known as the complement cascade, opening the way for a potential new class of treatments.

8 Sep 2021

Researchers generate first "atlas" of human melanocytes in the body

Researchers at Huntsman Cancer Institute at the University of Utah (U of U) have generated the first "atlas" of human melanocytes located throughout the body.

From The University of Utah 3 Sep 2021

therapeutics News and Research

New gel enhances immunotherapy's effectiveness in glioblastoma

Common drug to treat cancer reverses Alzheimer’s symptoms in mice

Researchers identify 14 genes responsible for obesity

Powerful method offers new insights about the dynamics of gliomas

Researchers develop key components of an expanded genetic code system

Gene expression changes help understand the mechanism behind noise-induced hearing loss

Researchers identify new protein that may critically contribute to severe COVID-19

Exploring cell and gene based therapies for Parkinson’s disease

Researchers identify host entry factor for Rift Valley fever virus

New map provides a reference to predict which antibodies are effective against SARS-CoV-2

Researchers show how 'bad mucin' contributes to worsening pulmonary conditions

Researchers find a new way to counter immunosuppressive effect in tumors

Study outlines the advantages of organoids for basic research into coronaviruses

Study reveals how the tumor suppressor gene plays a vital role in pediatric rhabdomyosarcoma

Scientists discover a new enzymatic complex that can halt cells from aging

UTHSC researcher receives grant to extend work on The Cancer Genome Atlas project

New drug-based genetic platform offers a simpler, more efficient way to study gene function

Scientists devise a strategy to enhance anti-tumor immunity

New technology harnesses a natural feature of therapeutic antibodies to attack blood cancer cells

Researchers generate first "atlas" of human melanocytes in the body

Expert Insights: HiMedia Labs on Advancing Nucleic Acid Extraction Across Industries

Quorum Bio: Where Synthetic Biology Meets Sustainable Farming

Diagnostic Biochips: Pioneering Brain Research Tools for the Future

Latest in Genomics